arrows arrow-right arrow-left menu search rss youtube linkedin twitter facebook instagram arrow-play linkedIn
Battelle Health & Analytics Newsletter

Battelle Health & Analytics Newsletter

News
graphic showing neurons firing

Douglas Weber to Lead Neurotechnology Development at Battelle

Battelle is pleased to welcome Douglas Weber to the Battelle Health Analytics team as the new Director of Neurotechnology Research and Development. A biomedical engineer and neurotechnology pioneer, Doug brings more than 20 years of experience on the front lines of neurotechnology innovation, with a career that has resulted in eight patents (and counting) and a biotechnology startup. 

At Battelle, Doug will first focus on further development of Battelle NeuroLife™, a groundbreaking neural bridging technology that allowed a paralyzed man to regain conscious, dexterous control of his hand and fingers. He plans to extend NeuroLife’s capabilities and make it accessible for more patients, including stroke and TBI patients and people with other types of movement disorders. 

Douglas WeberPrior to joining Battelle, Doug completed a four-year term as a Program Manager in the Biological Technologies Office at the Defense Advanced Research Projects Agency (DARPA) in Arlington, VA, where he created and managed a portfolio of programs providing over $300M in funding for neuroscience and neurotechnology research. Doug is also the cofounder of Bionic Power, Inc., a Vancouver-based biotechnology company that has invented a device that harvests energy produced by people’s legs as they walk.

In addition to his work at Battelle, Doug will retain his faculty position at the University of Pittsburgh, where he is an Associate Professor in the Departments of Bioengineering and Physical Medicine and Rehabilitation. Doug earned his M.S. and Ph.D. in Bioengineering from Arizona State University and completed postgraduate work at the University of Alberta Centre for Neuroscience. He holds a B.S. in Biomedical Engineering from Milwaukee School of Engineering. He is a member of the Society for Neuroscience, the American Physiological Society, and the Biomedical Engineering Society.